PAX1 and carcinoma: Hypermethylation at the PAX1 promoter and a reduction in PAX1 expression have also been reported in several different carcinomas, including cervical, ovarian, and colorectal carcinoma, although it is unclear whether these are related to tumor initiation, progression, or maintenance [125,126,165].